Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial-Reference-Cited by-同舟云学术

Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial

Published:2024-08-16 Issue:16 Volume:8 Page:4410-4413
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Venditti Adriano¹²^ORCID,Piciocchi Alfonso³^ORCID,Candoni Anna⁴⁵,Arena Valentina³^ORCID,Palmieri Raffaele¹^ORCID,Filì Carla⁴,Carella Angelo Michele⁶^ORCID,Calafiore Valeria⁷,Cairoli Roberto⁸,de Fabritiis Paolo⁹^ORCID,Storti Gabriella¹⁰,Salutari Prassede¹¹,Lanza Francesco¹²,Martinelli Giovanni¹³,Curti Antonio¹⁴^ORCID,Luppi Mario⁵,Ingrosso Claudia¹⁵,Martelli Maria Paola¹⁶^ORCID,Cuneo Antonio¹⁷^ORCID,Albano Francesco¹⁸^ORCID,Mulè Antonino¹⁹^ORCID,Tafuri Agostino²⁰,Cudillo Laura²¹,Tieghi Alessia²²,Fracchiolla Nicola Stefano²³,Capelli Debora²⁴^ORCID,Trisolini Silvia Maria²⁵,Alati Caterina²⁶,La Sala Edoardo³,Maurillo Luca²^ORCID,Del Principe Maria Ilaria¹²^ORCID,Irno Consalvo Maria Antonietta¹,Divona Maria Domenica²,Ottone Tiziana¹^ORCID,Cerretti Raffaella²^ORCID,Sconocchia Giuseppe²⁷^ORCID,Voso Maria Teresa¹²^ORCID,Fazi Paola³,Vignetti Marco³^ORCID,Buccisano Francesco¹²^ORCID

Affiliation:

1. 1Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy

2. 2Fondazione Policlinico Tor Vergata, Rome, Italy

3. 3GIMEMA Foundation, Rome, Italy

4. 4Clinica Ematologica, Azienda Ospedaliero-Universitaria “Santa Maria della Misericordia” di Udine, Italy

5. 5Ematologia, Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Università degli Studi di Modena e Reggio Emilia, Modena, Italy

6. 6Fondazione IRCCS Casa Sollievo della Sofferenza, UO di Ematologia, San Giovanni Rotondo, Italy

7. 7Ospedale Ferrarotto, Catania, Italy

8. 8ASST Grande Ospedale Metropolitano Niguarda-Milano; Università degli Studi di Milano-Bicocca, Milan, Italy

9. 9Hematology, S.Eugenio Hospital, ASL Roma 2, University Tor Vergata, Rome, Italy

10. 10Azienda Ospedaliera S. G. Moscati, Avellino, Italy

11. 11Azienda USL di Pescara, Pescara, Italy

12. 12Ematologia- Ospedale S. Maria delle Croci, Ravenna, Italy

13. 13IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori,” Meldola, Italy

14. 14IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli,” Bologna, Italy

15. 15A. O. SS Annunziata-P. O. S. G. Moscati, Taranto, Italy

16. 16Ospedale S. Maria della Misericordia, Perugia, Italy

17. 17Azienda Ospedaliero-Universitaria Arcispedale Sant'Anna, Ferrara, Italy

18. 18Hematology and Stem Cell Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari “Aldo Moro,” Bari, Italy

19. 19Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy

20. 20Ematologia, Azienda Ospedaliera Universitaria Sant' Andrea-Sapienza, Dipartimento di Medicina Clinica e Molecolare, Rome, Italy

21. 21UOC Ematologia, Azienda Ospedaliera S.Giovanni Addolorata, Rome, Italy

22. 22S. C. Ematologia AUSL-IRCCS Reggio Emilia, Italy

23. 23Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

24. 24Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, Italy

25. 25Haematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy

26. 26UOC Ematologia GOM Bianchi Melacrino Morelli, Reggio Calabria, Italy

27. 27Institute of Translational Pharmacology, National Research Council, Rome, Italy

Publisher

American Society of Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/8/16/4410/2240461/blooda_adv-2024-013182-main.pdf

Reference8 articles.

1. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN;Döhner;Blood,2022

2. Cytotoxic therapy in acute myeloid leukemia: not quite dead yet;Michaelis;Hematology Am Soc Hematol Educ Program,2018

3. 2021 update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party;Heuser;Blood,2021

4. Acute Myeloid Leukemia. Version 1.2009 . NCCN Clinical Practice Guidelines in Oncology. Accessed 12 January 2023. http://www.nccn.org/professionals/physician_gls/pdf/aml.pdf.

5. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia;Venditti;Blood,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?;Blood Reviews;2024-08